Skip to main content

Endovia Health Sciences, Inc.

EDVA
Exchange
NYSE
Industry
Beverages
SEC CIK
0001553788

No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Endovia Health Sciences, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of EDVA: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders913+4
Shares279.1K460.0K+180.8K (+64.8%)
Value$1.01M$919.0K−$94.0K (−9.3%)

New holders (7)

Institutions that held Endovia Health Sciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to EDVA in Q3 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC118,780$238.0K0.00%
Oppenheimer & Co Inc23,366$47.0K0.00%
Jane Street Group, LLC22,204$44.0K0.00%
Northern Trust Corp15,763$32.0K0.00%
Vanguard Group Inc14,290$29.0K0.00%
Berman Capital Advisors, LLC7,833$15.0K0.00%
Wells Fargo & Company121$00.00%

Sold out (3)

Institutions that held Endovia Health Sciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of EDVA in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Shay Capital LLC50,000$182.0K
Virtu Financial LLC23,120$84.0K
BDO Wealth Advisors, LLC1,527$6.00K